Seq and Ye Shall Find: Targeting Histology-Agnostic Gene Fusions to Improve Patient Outcomes

Pathologists will be able to detect actionable oncogenic gene fusions in patients, evaluate the efficacy and safety of therapies targeting oncogenic gene fusions, and accurately interpret and counsel colleagues on next-generation sequencing and molecular test results.

Share

Program Content

Activities

Histology Agnostic Gene Fusions
Seq and Ye Shall Find: Targeting Histology-Agnostic Gene Fusions to Improve Patient Outcomes
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: January 28, 2025

Expires: August 05, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

This activity is supported by an educational grant from Lilly.

Lilly